1. In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors
- Author
-
Xin Zhang, Mei Feng, Lin-Sheng Lei, Xue-Tao Xu, Peng-Fei Zheng, Jing Lin, Xiao-Zheng Wu, Cui-ying Liao, Shao-Hua Wang, You-Cheng Zhang, and Zhuang Xiong
- Subjects
Pharmacology ,Chemistry ,Stereochemistry ,In silico ,α glucosidase ,General Medicine ,molecular docking ,RM1-950 ,Methane ,In vitro ,bis (indol-3-yl) methanes ,inhibitor ,chemistry.chemical_compound ,α-amylase ,Drug Discovery ,α-glucosidase ,Therapeutics. Pharmacology ,Amylase inhibitors ,Research Article ,Research Paper - Abstract
In this paper, bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated for their inhibitory activity against α-glucosidase and α-amylase. All synthesised compounds showed potential α-glucosidase and α-amylase inhibitory activities. Compounds 5 g (IC50: 7.54 ± 1.10 μM), 5e (IC50: 9.00 ± 0.97 μM), and 5 h (IC50: 9.57 ± 0.62 μM) presented strongest inhibitory activities against α-glucosidase, that were ∼ 30 times stronger than acarbose. Compounds 5 g (IC50: 32.18 ± 1.66 µM), 5 h (IC50: 31.47 ± 1.42 µM), and 5 s (IC50: 30.91 ± 0.86 µM) showed strongest inhibitory activities towards α-amylase, ∼ 2.5 times stronger than acarbose. The mechanisms and docking simulation of the compounds were also studied. Compounds 5 g and 5 h exhibited bifunctional inhibitory activity against these two enzymes. Furthermore, compounds showed no toxicity against 3T3-L1 cells and HepG2 cells.HighlightsA series of bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated inhibitory activities against α-glucosidase and α-amylase.Compound 5g exhibited promising activity (IC50 = 7.54 ± 1.10 μM) against α-glucosidase.Compound 5s exhibited promising activity (IC50 = 30.91 ± 0.86 μM) against α-amylase.In silico studies were performed to confirm the binding interactions of synthetic compounds with the enzyme active site., Graphical Abstract
- Published
- 2021